Pamine (Methscopolamine Bromide) - Summary

PAMINE SUMMARY

Pamine^® 2.5 mg/Pamine^® Forte 5 mg Tablets

Pamine^® 2.5 mg/Pamine^® Forte 5 mg Tablets contain methscopolamine bromide, an anticholinergic agent.

Pamine (methscopolamine cation) is indicated for the following:

Adjunctive therapy for the treatment of peptic ulcer.

METHSCOPOLAMINE BROMIDE HAS NOT BEEN SHOWN TO BE EFFECTIVE IN CONTRIBUTING TO THE HEALING OF PEPTIC ULCER, DECREASING THE RATE OF RECURRENCE OR PREVENTING COMPLICATIONS.

PAMINE NEWS HIGHLIGHTS

Media Articles Related to Pamine (Methscopolamine)

Peptic Ulcer
Source: MedicineNet Bernard-Soulier Disease Specialty [2005.08.31]

Kids Protected From Asthma By Stomach Bug, NYU Study Finds
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.07.16]

more>>

Published Studies Related to Pamine (Methscopolamine)

Methscopolamine bromide blocks hypothalamic-stimulated release of growth hormone in ewes. [1997.05]

The muscarine antagonist methscopolamine and the NMDA antagonist AP-5 injected unilaterally into the nucleus accumbens cause mice to rotate in opposite directions. [1995]

Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements. [1994.01.24]

Seizure promotion by D1 agonists does not correlate with other dopaminergic properties. [1993]

more>>